Drugs & Pharmaceuticals

Join Cameron English and Dr. Chuck Dinerstein on Episode 117 of the Science Dispatch podcast as they discuss:

Unless you’ve been living in Bilbo Baggins’ Hobbit-burrow, you surely know that GLP1s (Glucagon-like peptide-1) and their “cousin,” GIP (glucose-dependent insulinotropic polypeptide), e.g., Ozempic, Munjaro, Zepbound, etc.

We dog owners do many things to keep our canine companions happy and healthy. I flew from San Francisco to Albuquerque last July to pick up a four-month-old Bedlington terrier and have seldom been separated from her since.

Cannabis laws in the U.S. are a masterclass in contradiction—both legal and chemical.

When President Donald Trump launched his bold trade policy agenda back in 2018, targeting China with sweeping tariffs, pharmaceuticals were conspicuously spared, unlike semiconductors, lumber, and copper, that were caught in the economic crossfire

On January 30th, in a landmark decision that could reshape the way acute pain is treated in the United States, the FDA

The question of whether current childhood vaccines are safer than the diseases they prevent continues to spark debate, despite the answer being as close to “settled science” as any.

All Medicare beneficiaries must have some form of Part D prescription drug coverage, either as a standalone product (PDP) or as part of a Medicare Advantage program (MA-PD).

It's a familiar complaint: The American health system is failing to deliver in part because of ever-rising drug prices.